# START-J: SiTAgliptin in eldeRly Trial in Japan

> **NCT01183104** · NA · COMPLETED · sponsor: **Japan Association for Diabetes Education and Care** · enrollment: 305 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Glimepiride

## Key facts

- **NCT ID:** NCT01183104
- **Lead sponsor:** Japan Association for Diabetes Education and Care
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2017-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183104, "START-J: SiTAgliptin in eldeRly Trial in Japan". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01183104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*